SESAMIN AND EPISESAMIN ARE INCORPORATED AT SPECIFIED WEIGHT RATIOS IN ORAL COMPOSITIONS SO THAT THE ORAL ABSORPTION OF EPISESAMIN AND/OR ITS TRANSFER INTO BLOOD CIRCULATION IS INCREASED. SESAMIN AND EPISESAMIN ARE ALSO INCORPORATED AT SPECIFIED WEIGHT RATIOS IN ORAL COMPOSITIONS SO THAT THE PHYSIOLOGICAL ACTIVITIES OF SESAMINS ARE ENHANCED.